Disclosures for "Basimglurant, a Novel mGluR5 Negative Allosteric Modulator, is Analgesic in Animal Models of Neuropathic and Chronic Pain"
-
Dr. Wettstein has received personal compensation for serving as an employee of Noema Pharma.
-
Dr. Roeloffs has received personal compensation for serving as an employee of Noema Pharma. Dr. Roeloffs has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Noema Pharma.
-
Dr. Garibaldi has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Knappertz has received personal compensation for serving as an employee of Noema Pharmaceuticals . Dr. Knappertz has received intellectual property interests from a discovery or technology relating to health care.